IPM Take
Survivorship is where cancer systems reveal whether they care about life after treatment. Standards alone do not change care. Patients need defined workflows, symptom monitoring, late-effects management, psychosocial support, referral tracking and someone clearly accountable for what happens after active treatment ends.
Executive Summary
A JAMA Network Open real-time Delphi study published in August assessed implementation readiness for the National Cancer Survivorship Care Standards. The study included 25 multidisciplinary survivorship experts from a National Cancer Institute-designated comprehensive cancer centre and affiliated community sites. Experts rated the standards as important and high-impact, but readiness gaps remained in formal policies, implementation consistency and evaluation mechanisms. The authors identified the need for defined clinical workflows, structured documentation, referral tracking and health-system metrics. Reported barriers included time constraints, workforce limitations, lack of standardised workflows and electronic health record limitations.
Why it matters
- Patients / advocates: Survivorship care should not depend on whether a patient knows what to ask after treatment ends.
- Clinicians: Late effects, recurrence anxiety, psychosocial needs and comorbidities require structured responsibility.
- Hospitals / providers: A standard without workflow design becomes another document no one has time to implement.
- Payers / public authorities: Survivorship care needs reimbursement and metrics, not only moral agreement.
Cancer survivorship is often treated as the good-news part of oncology.
That is lazy.
Survival can mean fatigue, neuropathy, sexual dysfunction, infertility, anxiety, fear of recurrence, cardiac risk, cognitive problems, financial damage and a maze of follow-up appointments. For many patients, the system becomes less organised at the exact moment they are expected to rebuild their lives.
The new JAMA Network Open study shows the problem clearly. Experts agreed that survivorship care standards are important. They also agreed, in effect, that the system is not ready enough to deliver them consistently.
That is the scandal. Not ignorance. Not lack of aspiration. Implementation failure.
The barriers are painfully familiar: time, workforce, missing workflows, weak documentation, limited referral tracking and electronic health records that do not support the work patients actually need. This is how standards die. Not by opposition, but by operational neglect.
The political issue is that survivorship is still too often unfunded work. Everyone supports it. Few systems build it properly. Oncology teams are already stretched. Primary care may not know what has happened in cancer treatment. Patients may not know which symptoms matter. Referrals may be made but not tracked. Mental health, rehabilitation and sexual health support may exist in theory but not in the patient’s reachable world.
Personalised medicine cannot end at the last infusion. A patient’s risk after cancer is also personal: treatment exposure, tumour type, age, comorbidities, social circumstances, family role, employment, geography and ability to navigate the system.
If survivorship standards are to matter, they need teeth: workflows, responsible teams, digital prompts, referral loops, funding, metrics and patient-facing plans that are actually used.
Otherwise, survivorship remains a promise laminated into a policy document.
